IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.128
AS - Asia 12.494
EU - Europa 12.061
SA - Sud America 3.791
AF - Africa 310
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 21
Totale 52.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.127
SG - Singapore 5.400
RU - Federazione Russa 4.446
BR - Brasile 3.110
CN - Cina 3.004
IT - Italia 2.474
GB - Regno Unito 1.606
VN - Vietnam 1.564
DE - Germania 981
HK - Hong Kong 884
CA - Canada 708
UA - Ucraina 432
IE - Irlanda 429
SE - Svezia 293
AR - Argentina 271
FI - Finlandia 270
IN - India 264
FR - Francia 225
TR - Turchia 215
MX - Messico 212
PL - Polonia 201
BD - Bangladesh 185
ID - Indonesia 183
NL - Olanda 175
IL - Israele 165
ZA - Sudafrica 146
ES - Italia 142
EC - Ecuador 139
JP - Giappone 130
IQ - Iraq 99
PK - Pakistan 96
AT - Austria 93
DK - Danimarca 69
CO - Colombia 68
AE - Emirati Arabi Uniti 57
LT - Lituania 55
MA - Marocco 50
PY - Paraguay 50
UZ - Uzbekistan 48
VE - Venezuela 43
CL - Cile 33
PE - Perù 31
BE - Belgio 28
KE - Kenya 27
CH - Svizzera 26
UY - Uruguay 25
EG - Egitto 24
SA - Arabia Saudita 22
TN - Tunisia 20
AZ - Azerbaigian 19
RO - Romania 18
EU - Europa 17
IR - Iran 17
CZ - Repubblica Ceca 16
DO - Repubblica Dominicana 16
AU - Australia 15
JO - Giordania 15
DZ - Algeria 14
BO - Bolivia 13
KZ - Kazakistan 12
NZ - Nuova Zelanda 11
AL - Albania 9
CR - Costa Rica 9
HN - Honduras 9
LB - Libano 9
MY - Malesia 9
NI - Nicaragua 9
NP - Nepal 9
AM - Armenia 8
KR - Corea 8
MC - Monaco 8
OM - Oman 8
TW - Taiwan 8
GE - Georgia 7
GT - Guatemala 7
GY - Guiana 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
BB - Barbados 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
HU - Ungheria 6
KG - Kirghizistan 6
PH - Filippine 6
TT - Trinidad e Tobago 6
JM - Giamaica 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
KW - Kuwait 4
ML - Mali 4
PS - Palestinian Territory 4
SI - Slovenia 4
BG - Bulgaria 3
BH - Bahrain 3
BN - Brunei Darussalam 3
GR - Grecia 3
HR - Croazia 3
LU - Lussemburgo 3
MD - Moldavia 3
Totale 52.766
Salva come PNG Salva come JPEG
Città #
Dallas 6.173
Singapore 2.875
Ashburn 1.470
Chicago 1.422
Beijing 1.387
Los Angeles 1.167
Hong Kong 825
Moscow 664
Salt Lake City 606
Chandler 562
Southend 543
Ho Chi Minh City 510
Fairfield 462
San Mateo 451
Buffalo 425
Dublin 423
Houston 382
Woodbridge 359
Wilmington 355
Hefei 350
Tampa 345
New York 343
The Dalles 343
Cambridge 320
São Paulo 317
Seattle 303
Elk Grove Village 269
Hanoi 256
Milan 252
Boardman 248
Portsmouth 242
Falls Church 237
Munich 234
Stevenage 215
Ann Arbor 212
Santa Clara 210
Rome 207
Ottawa 203
Pisa 200
Beauharnois 193
Jacksonville 179
Warsaw 179
Dearborn 156
Brooklyn 155
Lawrence 155
Tel Aviv 147
Florence 143
Montreal 141
London 133
Sterling 133
Istanbul 128
Lancaster 126
Dong Ket 117
Tokyo 115
Poplar 113
Stockholm 113
Frankfurt am Main 108
Denver 106
Rio de Janeiro 105
Johannesburg 97
Chennai 96
Nuremberg 96
Lappeenranta 94
Mexico City 93
Miami 93
Orem 92
Phoenix 92
Atlanta 86
Boston 86
Helsinki 84
Belo Horizonte 78
Dulles 78
Toronto 71
Turku 70
San Diego 64
Amsterdam 60
Brasília 58
Manchester 57
Haiphong 56
Ankara 55
Bologna 53
Detroit 53
San Francisco 53
Curitiba 52
Porto Alegre 52
Kansas City 51
Guangzhou 50
Washington 50
Da Nang 49
Council Bluffs 48
Quito 47
Biên Hòa 46
Lucca 45
Campinas 44
Guayaquil 44
Mumbai 44
Naples 42
Pittsburgh 42
Tashkent 42
Querétaro 41
Totale 31.716
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.791
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.591
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.505
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 826
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 657
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 546
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 400
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 325
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 307
Building medical knowledge from real world registries: The case of heart failure 306
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 303
A simple echocardiographic score to rule out cardiac amyloidosis 301
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 291
Treating chemoreflex in heart failure: modulation or demolition? 289
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 289
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 283
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 279
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 278
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 273
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 271
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 265
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 257
A simple echocardiographic score to rule out cardiac amyloidosis 252
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 250
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 243
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 242
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 234
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 233
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 232
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 232
Sex-related differences in chronic heart failure 231
How to take arms against central apneas in heart failure 230
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 230
Cardiac light-chain deposition disease relapsing in the transplanted heart 229
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 224
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 223
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 223
Unmet needs in end-of-life care for heart failure patients 220
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 219
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 217
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 217
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 216
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 215
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 215
Screening the health status of people working in a university 213
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 213
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 211
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 210
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 209
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 208
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 207
[Ten perspectives for research and innovation in cardiac amyloidosis] 206
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 204
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 203
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 203
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 202
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 201
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 201
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 199
Atrial amyloidosis: mechanisms and clinical manifestations 198
Biomarkers for the diagnosis and management of heart failure 197
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 196
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 194
Cardiac troponins as biomarkers for cardiac disease 192
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 192
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 188
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 188
Biomarkers for the diagnosis and management of heart failure: New frontiers 187
Cardiovascular disease and COVID-19: les liaisons dangereuses 186
Eligibility for vericiguat in a real‐world, contemporary heart failure population 185
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 184
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 183
Amiodarone as a possible therapy for coronavirus infection 181
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 181
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 179
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 179
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 179
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 178
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 178
Cardiac magnetic resonance in patients with muscular dystrophies 176
Role of Imaging in Cardiomyopathies 175
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 175
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 174
Management of complications of cardiac amyloidosis: 10 questions and answers 174
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 171
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 170
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences 169
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 169
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 168
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 168
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 167
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 167
Valvular heart disease in patients with cardiac amyloidosis 166
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 166
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 166
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 166
Subclinical cardiac damage in cancer patients before chemotherapy 166
Molecular autopsy of sudden cardiac death in the genomics era 166
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 165
Perspectives in noninvasive imaging for chronic coronary syndromes 164
Totale 27.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 293.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.541 0 0 0 0 0 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202623.467 2.194 6.182 4.866 5.533 4.011 681 0 0 0 0 0 0
Totale 53.235